InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Nau Jeffrey, Chief Executive Officer. Director active across 2 companies, notably Oyster Point Pharma, Inc.. Cumulatively, 9 disclosures have been logged. History available since 1 September 2021. The latest transaction was disclosed on 29 January 2022 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations9 total
2,607 shares@ US$11.709.3% of flowCommon StockSEC:0001209191-23-001084:0
8,938 shares@ US$11.2032.5% of flowCommon StockSEC:0001209191-22-060117:0
6,217 shares@ US$11.2022.6% of flowCommon StockSEC:0001209191-22-059794:0
46,700 shares0Common StockSEC:0001209191-22-002979:0
46,700 shares0Common StockSEC:0001209191-22-002979
50,000 shares@ US$1.0241.8% of flowCommon StockSEC:0001209191-21-061371:0
50,000 shares@ US$1.0214.9% of flowCommon StockSEC:0001209191-21-061371
10,000 shares@ US$1.028.2% of flowCommon StockSEC:0001209191-21-054298:0
10,000 shares@ US$1.022.9% of flowCommon StockSEC:0001209191-21-054298
9 of 9 declarations
About Nau Jeffrey
Jeffrey Nau is the President and Chief Executive Officer of Oyster Point Pharma, Inc. He leads the strategic operations of the company, focusing on innovation and growth. His leadership is essential in guiding Oyster Point to new heights.
